Learn More
CD267 Rat anti-Human, Brilliant Violet 421, Clone: 1A1-K21-M22 (also known as 1A1), BD Optibuild™
Descripción
The 1A1-K21-M22 monoclonal antibody specifically binds to CD267 which is also known as TACI (Transmembrane Activator and CAML Interactor). CD267 is a member of the of the Tumor Necrosis Factor Receptor (TNFR) Superfamily and is encoded by the TNFRSF13B gene. This 32 kDa type III transmembrane protein receptor binds to the ligands, BAFF (TNFSF13B/BLyS/CD257) and APRIL (TNFSF13/CD256). Ligand-bound CD267 transduces signals leading to the activation of transcription factors including NFAT, AP1, and NF-kappa-B. CD267 is expressed most notably on maturing subsets of B cells and myeloma cells. In CD267 deficient mice, B cell numbers are increased and mice develop autoimmune disorders suggesting that CD267 plays an important role in the regulation of B cell homeostasis.
Especificaciones
Especificaciones
| Antígeno | CD267 |
| Clasificación | Monoclonal |
| Clon | 1A1-K21-M22 (also known as 1A1) |
| Concentración | 0.2mg/mL |
| Conjugado | Brilliant Violet 421 |
| Formulación | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Alias de gen | TACI, TNFRSF13B, Tumor necrosis factor receptor 13B, TNFRSF14B2, CVID2 |
| Especie del huésped | Rat |
| Inmunógeno | Human TACI-transfected RBL cells |
| Método de purificación | Affinity Purified |
| Mostrar más |
Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.